Targeting	NN
sphingosine	NN
kinase	NN
1	CD
attenuates	VBZ
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
and	CC
progressive	JJ
interstitial	JJ
lung	NN
disease	NN
,	,
wherein	WRB
transforming-growth-factor-b	NN
(	(
TGF-b	NN
)	)
and	CC
sphingosine-1-phosphate	NN
(	(
S1P	NN
)	)
contribute	VBP
to	TO
the	DT
pathogenesis	NN
of	IN
fibrosis	NN
.	.

However	RB
,	,
the	DT
in	FW
vivo	FW
contribution	NN
of	IN
sphingosine	NN
kinase	NN
(	(
SphK	NN
)	)
in	IN
fibrotic	JJ
processes	NNS
has	VBZ
not	RB
been	VBN
documented	VBN
.	.

Microarray	NN
analysis	NN
of	IN
blood	NN
mononuclear	JJ
cells	NNS
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
SphK1	NN
-	:
or	CC
SphK2-knockdown	JJ
mice	NNS
and	CC
SphK	NN
inhibitor	NN
were	VBD
used	VBN
to	TO
assess	VB
the	DT
role	NN
of	IN
SphKs	NNS
in	IN
fibrogenesis	NN
.	.

The	DT
expression	NN
of	IN
SphK1/2	NN
negatively	RB
correlated	VBD
with	IN
lung	NN
function	NN
and	CC
survival	NN
in	IN
patients	NNS
with	IN
IPF	NN
.	.

Also	RB
,	,
the	DT
expression	NN
of	IN
SphK1	NN
was	VBD
increased	VBN
in	IN
lung	NN
tissues	NNS
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
bleomycin-challenged	JJ
mice	NNS
.	.

Knockdown	NNP
of	IN
SphK1	NN
,	,
but	CC
not	RB
SphK2	NN
,	,
increased	VBD
survival	NN
and	CC
resistance	NN
to	TO
pulmonary	JJ
fibrosis	NN
in	IN
bleomycin-challenged	JJ
mice	NNS
.	.

Administration	NN
of	IN
SphK	NN
inhibitor	NN
reduced	VBD
bleomycin-induced	JJ
mortality	NN
and	CC
pulmonary	JJ
fibrosis	NN
in	IN
mice	NNS
.	.

Knockdown	NNP
of	IN
SphK1	NN
or	CC
treatment	NN
with	IN
SphK	NN
inhibitor	NN
attenuated	VBD
S1P	NN
generation	NN
and	CC
TGF-b	NN
secretion	NN
in	IN
a	DT
bleomycin-induced	JJ
lung	NN
fibrosis	NN
mouse	NN
model	NN
that	WDT
was	VBD
accompanied	VBN
by	IN
reduced	VBN
phosphorylation	NN
of	IN
Smad2	NN
and	CC
MAPKs	NNS
in	IN
lung	NN
tissue	NN
.	.

In	FW
vitro	FW
,	,
bleomycin-induced	JJ
expression	NN
of	IN
SphK1	NN
in	IN
lung	NN
fibroblast	NN
was	VBD
found	VBN
to	TO
be	VB
TGF-b	JJ
dependent	JJ
.	.

Taken	VBN
together	RB
,	,
these	DT
data	NNS
indicate	VBP
that	IN
SphK1	NN
plays	VBZ
a	DT
critical	JJ
role	NN
in	IN
the	DT
pathology	NN
of	IN
lung	NN
fibrosis	NN
and	CC
is	VBZ
a	DT
novel	JJ
therapeutic	JJ
target	NN
.	.

